YOUNGIL KOH
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma (NCT06645678) | YOUNGIL KOH | 2024-11-26 |
Track YOUNGIL KOH automatically
Every clearance here is in the API, with alerts when new ones post.